Ogorek Anthony Joseph Eli Lilly & CO Transaction History

Ogorek Anthony Joseph

$288 Million
Q1 2024

A detailed history of Ogorek Anthony Joseph transactions in Eli Lilly & CO stock. As of the latest transaction made, Ogorek Anthony Joseph holds 11,170 shares of LLY stock, worth $10.2 Million. This represents 3.02% of its overall portfolio holdings.

Number of Shares

11,170

Previous 11,297 1.12%

Holding current value

$10.2 Million

Previous $6.59 Million 31.95%

% of portfolio

3.02%

Previous 2.39%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $75,209 - $100,619	-127 Reduced 1.12%	11,170 $8.69 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $13,129 - $15,478	-25 Reduced 0.22%	11,297 $6.59 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $34,776 - $47,944	-80 Reduced 0.7%	11,322 $6.08 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $56,118 - $75,036	160 Added 1.42%	11,402 $5.35 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $77,346 - $90,840	249 Added 2.27%	11,242 $3.86 Million

Q4 2022 Jan 30, 2023	SELL	$321.55 - $374.67 $23,151 - $26,976	-72 Reduced 0.65%	10,993 $4.02 Million
Q3 2022 Oct 20, 2022	BUY	$296.48 - $337.87 $17,195 - $19,596	58 Added 0.53%	11,065 $3.58 Million
Q2 2022 Jul 21, 2022	BUY	$278.73 - $327.27 $69,682 - $81,817	250 Added 2.32%	11,007 $3.57 Million
Q1 2022 Apr 26, 2022	BUY	$234.69 - $291.66 $764,620 - $950,228	3,258 Added 43.45%	10,757 $3.08 Million
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $1.65 Million - $2.05 Million	7,349 Added 4899.33%	7,499 $2.07 Million
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $21,933 - $25,369	150 New	150 $22,000

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.

Account

Ogorek Anthony Joseph Eli Lilly & CO Transaction History